Bct.To

BIOCTAVE INC has a strong liquidity position, with a current ratio of 5.01, indicating the company can cover its short-term liabilities more than five times over with its current assets. The company holds $10,493,810 in cash and equivalents, while its total liabilities amount to $3,768,870, and it has no long-term debt. This liquidity position is supported by a debt-to-equity ratio of 0, suggesting the company is not leveraged and is not using debt to finance its operations.

The company's profitability is currently negative, with a return on equity of -1.47 and a return on assets of -1.2153, indicating that it is not generating returns for its shareholders or effectively utilizing its assets. The operating and net income are both negative, at -$27,204,800 and -$26,311,870, respectively, which suggests the company is not yet profitable and is likely in a growth or development phase.

There is no detailed information provided on the company's segments or geographic exposure, but the absence of revenue data implies that the company may not have disclosed its revenue by segment or region. The company's growth trajectory is not clearly defined, as there is no revenue history provided, and the analyst estimates for the last actual revenue are reported as $0.00.

The risk assessment indicates that there are no immediate filing-based liquidity or dilution flags, and the company is currently rated as having low liquidity and dilution risk. The company has not issued any new shares recently, and there is no indication of dilution pressure in the near term.

There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial status. The company's financial snapshot does not include any recent transcripts or filings that would provide insight into its strategic direction or operational performance.